Mercury Medical forms U.S. distribution agreement with Medovate

December 17, 2020 – Mercury Medical (Clearwater, FL) has formed an agreement with Medovate (UK) to distribute its medical device SAFIRA (SAFer Injection for Regional Anesthesia) regional anesthesia device in the U.S.

SAFIRA is an FDA-cleared Class II medical device “set to transform regional anesthesia around the world by making it a one-person procedure,” the company says. The device puts control of the injection in the hands of the anesthesiologist, freeing up assistants to carry out other tasks. The company also says the device helps to improve patient safety by reducing the risk of nerve damage as it prevents injection above 20psi.

Mercury Medical will distribute SAFIRA throughout 28 U.S. states. This will cover the East Coast, the Southern states and the West Coast including the states of New York, Delaware, Florida, New Jersey, North Carolina, South Carolina, Texas, Mississippi and California.

Learn More